What is the door to needle time goal for 85% or more of acute ischemic stroke patients treated with IV thrombolytics?

The goal for door to needle time for acute ischemic stroke patients treated with IV thrombolytics is indeed 60 minutes or less. This target is critical because timely administration of thrombolytics can significantly improve outcomes by allowing for the restoration of blood flow to the brain, potentially minimizing brain damage and improving functional recovery.

Research has shown that the chance of a favorable outcome decreases as time passes after the onset of stroke symptoms. Therefore, achieving this 60-minute benchmark ensures that treatment is initiated rapidly, which is crucial given the time-sensitive nature of stroke care.

Other times, such as 30 minutes, might be ideal in a perfect scenario but are not the established goal for the majority of patients. Timeframes such as 90 minutes or 120 minutes are considered too long and could lead to worse patient outcomes due to delays in treatment, emphasizing the urgency of achieving the set target of 60 minutes.